Previous work from our laboratory showed that motor nerve injury by lumbar 5 ventral root transection (L5-VRT) led to interleukin-6 (IL-6) over-expression in bilateral spinal cord, and that intrathecal administration of IL-6 neutralizing antibody delayed the induction of mechanical allodynia in bilateral hind paws. However, early events and upstream mechanisms underlying spinal IL-6 expression following L5-VRT require elucidation. The model of L5-VRT was used to induce neuropathic pain, which was assessed with von Frey hairs and the plantar tester in adult male Sprague-Dawley rats. Calpain-2 (CALP2, a calcium-dependent protease) knockdown or over-expression and microglia depletion were conducted intrathecally. Western blots and immunohistochemistry were performed to explore the possible mechanisms. Here, we provide the first evidence that both IL-6 and CALP2 levels are increased in lumbar spinal cord within 30 min following L5-VRT. IL-6 and CALP2 co-localized in both spinal dorsal horn (SDH) and spinal ventral horn. Post-operative (PO) increase in CALP2 in ipsilateral SDH was evident at 10 min PO, preceding increased IL-6 at 20 min PO. Knockdown of spinal CALP2 by intrathecal CALP2-shRNA administration prevented VRTinduced IL-6 overproduction in ipsilateral spinal cord and alleviated bilateral mechanical allodynia. Spinal microglia activation also played a role in early IL-6 up-regulation. Macrophage/microglia markers ED1/Iba1 were increased at 30 min PO, while glial fibrillary acidic protein (astrocyte) and CNPase (oligodendrocyte) markers were not. Increased Iba1 was detected as early as 20 min PO and peaked at 3 days. Morphology changed from a small soma with fine processes in resting cells to an activated ameboid shape. Depletion of microglia using Mac-1-saporin partially prevented IL-6 upregulation and attenuated VRT-induced bilateral mechanical allodynia. Taken together, our findings provide evidence that increased spinal cord CALP2 and microglia cell activation may have early causative roles in IL-6 over-expression following motor nerve injury. Agents that inhibit CALP2 and/or microglia activation may therefore prove valuable for treating neuropathic pain.
Nervous system lesions or inflammation can result in chronic neuropathic pain, characterized by increased sensitivity to painful stimuli (hyperalgesia), decreased pain threshold (allodynia), and spontaneous pain. Effective treatments are still largely unavailable, mainly because of lack of understanding of underlying mechanisms contributing to different stages of pathophysiology. Thus, an important goal of current research is to clarify the early pathophysiological mechanisms underlying neuropathic pain. A rat model of selective injury to motor fibers by L5 ventral root transection (L5-VRT) producing persistent mechanical allodynia and thermal hyperalgesia in bilateral hind paws (Li et al. 2002; Wu et al. 2002; Obata et al. 2006; Xu et al. 2006 Xu et al. , 2007 He et al. 2010; Wei et al. 2013; Zang et al. 2015) mimics clinical pain symptoms associated with post-poliomyelitis (Stoelb et al. 2008; Rekand et al. 2009; Werhagen and Borg 2010) . This model can be used to analyze neuroinflammatory mechanisms underlying neuropathic pain without primary afferent injury.
Accumulating evidence shows that neuroinflammatory responses in both the peripheral and central nervous system play critical roles in the development of chronic pain (Scholz and Woolf 2007) . Particular attention has focused on proinflammatory cytokines (Moalem and Tracey 2006) . Levels of interleukin 6 (IL-6), a pleiotropic cytokine, are increased in uninjured dorsal root ganglion (DRG) neurons within 30 min following L5-VRT (Zang et al. 2015) , and intrathecal administration of IL-6-neutralizing antibodies can delay L5-VRT-induced mechanical allodynia in bilateral hind paws (Wei et al. 2013) . Recent clinical data indicate that high serum IL-6 levels at the time of patient hospitalization may predict development of chronic pain after disc herniation (Schistad et al. 2014) . A cross-sectional study of proinflammatory markers in chronic neuropathic pain patients showed increased IL-6 in disc hernia patients compared to controls, while other inflammatory markers such as IL-1b, IL-8, and GM-CSF were not affected (Backryd 2016 ). IL-6-targeted therapy has been used successfully to treat chronic pain (Kelleher et al. 2017) : the anti-IL-6 receptor monoclonal antibody, tocilizumab, has been effective in treating sciatica (Ohtori et al. 2012 ) and sgp130, a selective inhibitor of IL-6 trans-signaling, improved outcomes in neuroinflammation and pain treatment (Lissilaa et al. 2010) . Better treatment efficacy may be possible with enhanced understanding of early spinal IL-6 expression, based upon studies using the L5-VRT rodent model.
Calpain is a calcium-dependent cysteine protease consisting of calpain-1 (l-calpain) and calpain-2 (CALP2, mcalpain), which differ in sensitivity to intracellular free calcium concentrations (Sorimachi and Suzuki 2001; Croall and Ersfeld 2007) . Calpain is abundantly expressed in the central nervous system (CNS) (Ray and Banik 2003) and is found in cell membranes and cytosol (Banik et al. 1985) . Intracellular calpain is involved in normal physiological functions (Liu et al. 2008; Zadran et al. 2010; Baudry et al. 2013; Tyagarajan et al. 2013 ) but abnormal calpain activation is implicated in cellular injury in multiple neurodegenerative diseases (Ma 2013; Trager et al. 2014; Samantaray et al. 2015) . Axonal transection triggers a transient influx of calcium (in the millimolar range) near the tip of the cut axon (Ziv and Spira 1995) . The transient elevation of calcium near the axon cut end temporally activates calpain at very early stage (1 h) after nerve transection (Glass et al. 2002) , which occurs long before the onset of neuropathic pain. The subsequent calpain activation is required for post-axotomy axonal degeneration (Ma 2013; Ma et al. 2013; Yang et al. 2013) . We showed that L5-VRT transiently activates CALP2 in both distal-and proximal-stumps of nerve root between 10 and 180 min following nerve injury (Zang et al. 2015) , suggesting that the neurodegenerative process in the transected motor fiber is triggered at an early stage. Degeneration in myelinated efferent fibers is sufficient to induce spontaneous activity in unmyelinated C-fiber afferents (Wu et al. 2002) , and pre-treatment with the calpain inhibitor MDL28170 blocked abnormal early IL-6 expression in primary afferent neurons and attenuated mechanical allodynia in the L5-VRT rat model (Zang et al. 2015) .
Bidirectional communication between neurons and microglia in neurodegenerative disease has gained attention in recent years. Persistently damaged neurons release cytotoxic factors and calpain, which activate microglia (Podbielska et al. 2016) . Microglia, resident immune effector cells of the central nervous system, are activated by neuronal damage and release pro-inflammatory cytokines (McMahon et al. 2005; Balasubramaniam et al. 2009 ) and calpain (Podbielska et al. 2016 ) which contribute to surrounding neuron damage (Dheen et al. 2007; Whitney et al. 2009 ). Because microglia play a more important role in the initiation of neuropathic pain, while astrocytes are more responsible for neuropathic pain persistence (Colburn et al. 1999; Raghavendra et al. 2003) , and early activation of CALP2 but not calpain-1 upregulates IL-6 in bilateral uninjured L4-L6 DRG neurons (Zang et al. 2015) , this study was designed to further elucidate the early expression of spinal IL-6 both in neurons and microglia following L5-VRT and reveal potential upstream CALP2 activation mechanisms.
Materials and methods

Animals care
Experiments were performed on male Sprague-Dawley rats (150-180 g) obtained from the Animal Experimental Center, Sun Yat-Sen University, China (License number SCXK (yue) 2008-0002). The rats were housed (one rat per cage) in a 20-24°C-controlled room with free access to sterile water and standard laboratory chow. The type of cage we used was an automatic full-membrane individual ventilated caging system (IVC) purification cage (XDWG-25, Suzhou Junshen Experiment Animal Equipment Ltd. Suzhou, China). For each experiment, we used about 15 cages. All experimental procedures were approved by the Animal Care Committee of Sun Yat-Sen University and were carried out in accordance with the guidelines of the National Institutes of Health on animal care and the ethical guidelines for investigation of experimental pain in conscious animal (Zimmermann 1983) . Our study was not pre-registered. The animals with the following conditions were excluded. (i) Paralyzed feet after a failed VRT modeling; (ii) Abnormal thresholds of basal behavioristics; (iii) Died shortly after surgery; (iv) Damaged spinal cord or serious abdominal infection during drug administration.
Sample inclusion/exclusion criteria Samples collected in the same basic conditions and interventions and without experimental errors were included, while samples having experimental errors and significant defect or disease caused by non-human factors were excluded. All experiments were performed in a double-blinded manner. Statistical methods were not used in this study to predetermine the sample size.
L5 ventral root transection L5-VRT was performed as described previously (Li et al. 2002; Zang et al. 2010 Zang et al. , 2015 . Briefly, surgery and experimental procedures on rats were performed under 0.4% sodium pentobarbital anesthesia (40 mg/kg body weight, i.p.), which is generally used for major surgery (L5-VRT) that easily causes bleeding and is suitable for our experiments that need the animals to be survived for at least 14 days for behavioral test. An L5 hemi-laminectomy was performed to expose the L5 nerve root. The ventral root was pulled out with fine forceps and transected 2-3 mm proximal to the DRG, and a small portion (2 mm) of the root was removed. In the sham operated rat, an identical operation was performed for exposure of L5 ventral root, but the nerve was not transected. A complete hemostasis was confirmed and the wound was sutured in two layers.
Measurement of calpain activity
Quantitative and spatial analysis of neuronal calpain activity were performed by determining the accumulation of selective spectrin breakdown products (SBDP) generated by calpain-mediated proteolysis in tissues of the central nervous system (CNS) with an antispectrin aII antibody (MAB1622; Chemicon, Temecula, CA, USA). (Bi et al. 1996; Castejon et al. 1999; Glass et al. 2002; Zadran et al. 2010; Zang et al. 2015) .
Intrathecal injection
A sterile catheter (PE-10 tube) was inserted through the gap between L5 and L6 vertebrae and extended to the subarachnoid space of the lumbar enlargement (L4 and L5 segments) under 4% isoflurane (v/ v) anesthesia , which is generally used for the minor surgery with less bleeding and suitable for experiments that need long-term breeding/survival post-surgery during which multiple times of anesthesia can also be performed, and has the benefits of faster recovery and less possibility to get abdominal infection and inflammatory reactions. One week after catheter placement, intrathecal injection of drugs was performed in a total volume of 10 lL followed by 10 lL saline, to flush the catheter. A flowchart for our experimental design is provided in Fig. 1 .
Behavioral tests for allodynia
Mechanical allodynia was assessed by the up-and-down method described previously (Chaplan et al. 1994) . Briefly, a series of von Frey hairs of logarithmically incremental stiffness (0.4, 0.6, 1.0, 2.0, 4.0, 6.0, 8.0, and 15.0 g) were applied with sufficient force to the mid-plantar of both rat hind paws. The 2.0 g stimulus, in the middle of the series, was used first. In the event of absent paw withdrawal, the next stronger stimulus was chosen. In the case of initial paw withdrawal, the next weaker stimulus was applied. By repeating this procedure the stimulation strength corresponding to a 50% response rate was determined by interpolation. Six to nine rats were used in each group.
Immunohistochemistry
Immunofluorescence staining procedures were performed as previously described Wei et al. 2013; Zang et al. 2015) . Briefly, animals were anesthetized and perfused with saline followed Fig. 1 The flowchart of this experimental procedure. Rats with normal baseline levels of paw withdrawal thresholds were first chosen by behavioral tests, and then received sham/ventral root transection (VRT) surgery after which the protein levels of CALP2, IL-6, Iba1, ED1, GFAP, and CNPase were examined by western blot and immunohistochemistry at the time points of post-operative (PO) 10 and 30 min. Furthermore, catheter placement and knockdown of CALP2/depletion of microglia were performed 7 and 3 days, respectively, before Sham/ VRT surgery to evaluate the effects of drug administration on CALP2, IL-6, and Iba1 expression levels at PO 30 min by western blot and immunohistochemistry, and on the paw withdrawal thresholds PO day 7 or 14 by behavioral test.
by 4% paraformaldehyde in 0.1 M phosphate buffer (Wu et al.) . After perfusion, the lumbar spinal cord segments were removed and post-fixed in the same fixative for 3 h, then replaced with 30% sucrose overnight. Spinal cord tissue was sectioned (25 lm thickness) on a freezing microtome (LEICA CM3050S, Wetzlar, Germany). The spinal cord sections were selected by two experimenters in a double-blinded manner. Sections with lumbar enlargement from the same group were placed in a same well by the first experimenter. No randomization methods were employed in this work and the spinal cord sections were arbitrarily chosen. Sections were blocked with 3% donkey serum for 1 h at 20-24°C, and incubated with anti-IL-6 antibody (1 : 100; R & D Systems, Minneapolis, MN, USA), anti-CALP2 antibody (1 : 100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), or Iba1 (microglia marker; San Francisco, Abcam) at 1 : 500 over two nights at 4°C. Following primary antibody incubation, sections were incubated for 1 h 20-24°C with secondary antibodies. For double immunofluorescence staining, spinal cord sections were incubated with a mixture of anti-IL-6 antibody (1 : 100; R & D Systems) or anti-CALP2 antibody (1 : 100; Santa Cruz Biotechnology) plus monoclonal neuronal-specific nuclear protein (NeuN; neuronal marker, 1 : 200; Chemicon), glial fibrillary acidic protein (GFAP, astrocyte marker, 1 : 500; Chemicon), or Iba1 (1 : 500; Abcam) over two nights at 4°C. After the primary antibody incubation, sections were then treated with a mixture of FITC-and Cy3-conjugated secondary antibodies for 1 h 20-24°C. The sections were rinsed with 0.01 M phosphate-buffered saline three times, mounted on gelatin-coated slides, and air-dried. Specimens were imaged with a fluorescence microscope attached to a CCD spot camera (LEICA DFC350FX/ DMIRB) and then processed with LEICA IM50 software by an assistant who did not know the exact meaning of the marked letters. Cells positive for IL-6 or CALP2 and the cell-specific marker appeared yellow when viewed with a dual-pass fluorescence filter.
To verify immunospecificity, negative control sections were processed identically, omitting the primary antibody as described previously (Wei et al. 2013) .
Western blot analysis
Three rats were used in each group. As described previously (Wei et al. 2013) , animals were decapitated and the L4-L6 spinal cord quickly removed (the dorsal horn was separated from ventral horn in some rats) and homogenized in 15 mM Tris buffer at pH 7.6 containing a protease inhibitor cocktail (Roche Molecular Biochemicals, Indianapolis, IN, USA). Total protein concentration was determined by bicinchoninic acid protein assay (Pierce, Rockford, IL, USA). The protein samples were separated by electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA, USA). After blocking at room temperature for 1 h, the membranes were incubated in the primary antibody overnight at 4°C. Membranes were then washed and incubated with horseradish peroxidase conjugated IgG (Cell Signaling Technology, Beverly, MA, USA). After washing, immune complexes were detected by enhanced chemiluminescence (Bio-Rad) using the Tanon-5200 Chemiluminescent Imaging System (Tanon Science and Technology, Pujiang High-tech Park, Shanghai, China). The band intensities were quantitatively analyzed by densitometry using a computer-assisted imaging analysis system (KONTRON IBAS 2.0, Augsburg, Germany).
Adenovirus-mediated knockdown of CALP2 by RNA interference shRNA targeting rat CALP2 mRNA (PAVT1389; GenBank accession no. NM_017116) and scrambled control sequences (lacking homology to any known Rattus norvegicus mRNAs) were designed and synthesized by Shanghai Sunbio Medical Biotechnology AdCenter (Sunbio, Shanghai, China). Two sets of oligonucleotides: shCALP2 (Forward, ATATGTCCTTGTTCCTTCC; Reverse, TAGTCAGCCTTCTTCTCT) and scrambled sequence (Forward, TCCCTCAAGATTGTCAGCAA; Reverse, AGATCCACAACGG ATACATT) were synthesized. These oligonucleotides were cloned into pAVT/U6 vector following the manufacturer's instructions. All clones were verified by direct sequencing. Adenovirus expression plasmids (pAd/BLOCK-it DEST bearing shCALP2 sequences) were digested with PacI to expose the inverted terminal repeats and were transfected into 293A producer cells with Lipofectamine 2000 (Sun Bio) to produce adenovirus stock. Amplified adenovirus was used to knockdown CALP2. Western blot and casein zymography were performed to measure protein and enzyme activity levels, respectively.
Depletion of microglia
Mac-1-saporin, a chemical conjugate of rat Mac-1 (CD11b) monoclonal antibody and the ribosome-inactivating protein saporin (Advanced Targeting Systems, San Diego, CA, USA), was used to selectively kill spinal cord microglia expressing CD11b (Kanai et al. 2006; Zhao et al. 2007; Ferrini et al. 2013; Nunan et al. 2014) . Dosage was based on previous reports (Ferrini et al. 2013; Li et al. 2015) . Intrathecal injection of Mac-1-saporin (2 lg/L, 10 lL), saporin (2 lg/L, 10 lL) and vehicle (NaCl, 10 lL) were performed 3 days before sham or VRT surgery.
Antibodies
The following primary antibodies were used: rabbit anti-IL-6 (1 : 200, Catalogue Number: ab6672; Abcam, RRID: AB_2127460), Rat IL-6 antibody (1 : 100, Catalogue Number: AF506; R & D Systems, RRID:AB_355398), goat anti-CALP2 (1 : 100, Catalogue Number: sc-7533; Santa Cruz Biotechnology, RRID:AB_2069635), rabbit anti-CALP2 (1 : 100, Catalogue Number: ab39165; Abcam, RRID:AB_725844), mouse anti-spectrin a (1 : 500, Catalogue Number: MAB1622; Chemicon, RRID: AB_11214057), mouse anti-b-actin (1 : 500, Catalogue Number: BM0627; Boster, Wuhan, China), mouse anti-NeuN (1 : 200, Catalogue Number: MAB377; Chemicon, RRID:AB_2298772), mouse anti-GFAP (1 : 500, Catalogue Number: MAB3402; Chemicon, RRID:AB_94844), Goat anti-Iba1 (1 : 500, Catalogue Number: ab5076; Abcam, RRID:AB_2224402), mouse anti-rat monocytes/Macrophages (1 : 200, ED1, Catalogue Number: MAB1435; Chemicon, RRID:AB_177576), and mouse antiCNPase 
Quantitation and statistics
The quantitation of immunofluorescence was performed by measuring the intensity of IL-6, CALP2, or Iba1 immunoreactivity (IR) per section in spinal dorsal horn and ventral horn. Images were analyzed using LEICA Qwin V3 digital-image processing system. Iba1-IR and IL-6-IR-positive cells per section were counted to validate microglia elimination after Mac-1-saporin treatment. Four to six spinal cord sections from each animal were examined. An intensity ratio of IR relative to the control or percentage of Iba1-IR and IL-6-IR-positive cells relative to the total number of cells were obtained across the different tissue sections from each animal, and the mean AE SE across animals (n = 5) was determined (Xu et al. 2006; Wei et al. 2007) .
Analysis was performed blind. Statistical analysis was performed using SPSS 10.0 (SPSS Inc., Chicago, USA). Differences were tested using one-way ANOVA followed by a Tukey post hoc test, or Student's t-test if only two groups were compared. For behavioral tests, two-way ANOVA with Dunnett's multiple comparisons test and non-parametric tests were employed including Kruskal-Wallis H test and Wilcoxon signed-rank test. Data were presented as mean AE SE. For all comparisons p < 0.05 was considered statistically significant.
Results
IL-6 is up-regulated in spinal cord very early after motor fiber injury
We examined IL-6 levels in spinal cord within 30 min of L5-VRT. As shown in Fig. 2a -c, IL-6 IR was dramatically increased in bilateral (ipsilateral and contralateral) spinal dorsal horn (SDH) and spinal ventral horn (SVH) at 30 min post-operative (PO). Compared to controls (naive), no significant difference in IL-6 IR was observed within 10 min PO. Western blot analysis confirmed increased IL-6 protein levels at 30 min PO (Fig. 2d and e) . To identify the cells responsible for early increases in spinal cord IL-6, double immunolabeling studies were performed showing that IL-6 co-localized with NeuN (neuronal marker) and Iba1 (microglia marker), but not GFAP (astrocyte marker) in SDH (Fig. 2f) and SVH (Fig. 2g) at 30 min PO.
CALP2 is responsible for IL-6 over-expression and induction of neuropathic pain To examine the role of CALP2 in spinal cord IL-6 overexpression, we first measured early changes in CALP2. Western blot analysis showed that CALP2 levels in L5-VRT rats were increased significantly compared to naive and sham-operated rats in ipsilateral (Ipsi) SDH (Fig. 3a and b) and SVH ( Fig. 3c and d) , but not in the contralateral (Polazzi & Contestabile) side at 10 and 30 min PO (Fig. 3a-d) . To determine the calpain enzymatic activity, we examined the protein level of calpain-mediated spectrin breakdown products (SBDP). The SBDP level was strikingly up-regulated in ipsilateral spinal cord at PO 30 min when calpain-2 reached its peak level. In contrast, the SBDP level was not significantly changed in contralateral side (Fig. 3e and f) . The up-regulation of both calpain-2 and SBDP protein levels in ipsilateral spinal cord proved the activation of calpain. Double immunolabeling of spinal CALP2 with cell markers showed CALP2 co-localization with NeuN but not GFAP or Iba1 in SDH (Fig. 3g) and SVH (Fig. 3h) at 30 min PO. In the same condition, we found that CALP2 is co-localized with IL-6 (Fig. 4a) . We next examined the expression levels of CALP2 and IL-6 in the L5-VRT rats at different time points, including 5, 10, 20, and 30 min. The data showed that increased CALP2 IR was detectable in ipsilateral SDH at 10 min PO, while elevated IL-6 was evident at 20 min ( Fig. 4b and c) . These results indicated that early upregulation of CALP2 partly overlapped with that of IL-6.
We then analyzed the effects of spinal CALP2 knockdown on IL-6 over-expression and VRT-induced mechanical allodynia. Three days before sham or VRT surgery, adenovirus expressing CALP2-specific shRNA (CALP2-shRNA; PAVT1389) was injected intrathecally into the lumbar enlargement of the spinal cord (Fig. 5a ). VRT rats administered NaCl or scramble control shRNA (PAVT1) served as controls. Western blot analysis showed that pre-treatment with CALP2-shRNA (PAVT1389) suppressed over-expression of CALP2 and prevented VRT-induced IL-6 upregulation 30 min PO partially in ipsilateral SDH and completely in SVH. Administration of scramble control shRNA (PAVT1) altered neither CALP2 nor IL-6 levels compared to controls (Fig. 5b and c) . We evaluated the effect , and quantification shown in (e). b-actin was used as a loading control. N = 3 rats/group, **p < 0.01, ***p < 0.001 (Student's t-test) versus sham group. (f and g) Representative double immunofluorescence labeling of IL-6 and cell markers in ipsilateral spinal cord. In both SDH (f) and SVH (g), IL-6 (red) co-localized with NeuN (a neuronal marker, green) and Iba1 (a microglia marker, green), but not GFAP (an astrocyte marker, green) at PO 30 min. Scale bar = 50 lm.
of CALP2 inhibition on bilateral paw withdrawal thresholds. As described previously (Li et al. 2002; Xu et al. 2006; He et al. 2010; Zang et al. 2015) L5-VRT surgery led to strong mechanical allodynia in bilateral hind paws on day 3, with hypersensitivity continuing until at least day 14 PO (Fig. 6a  and b) . Mechanical paw withdrawal thresholds in rats The early changes of calpain-mediated spectrin breakdown products (SBDP) were also analyzed by western blot. b-actin was used as a loading control. At PO 30 min, SBDP was increased significantly in ipsilateral spinal cord, whereas no changes were observed in contralateral side. (f) Quantification for the data in (e). N = 3 rats/group, *p < 0.05, **p < 0.01, ***p < 0.001 (one-way ANOVA). (g and h) Double immunofluorescence labeling in SDH (g) and SVH (h) showed CALP2 (green) co-localized with NeuN (a neuronal marker, red; left), but not glial fibrillary acidic protein (an astrocyte marker, red; middle) or Iba1 (a microglia marker, red; right). Scale bar = 50 lm.
injected with PAVT1 ( Fig. 6c and d) did not differ from sham-operated controls that received NaCl intrathecally ( Fig. 6a and b) , and PAVT1 pre-treatment did not attenuate VRT-induced mechanical allodynia ( Fig. 6c and d) . However, intrathecal PAVT1389 significantly prevented the decreases in bilateral paw withdrawal thresholds induced by L5-VRT and this effect persisted until PO day 14 ( Fig. 6e  and f ). These observations suggest that interfering with IL-6 up-regulation by selective inhibition of CALP2 could modulate behavioral hypersensitivity evoked by L5-VRT.
The role of activated microglia in IL-6 up-regulation and mirror-image pain CALP2 increased ipsilaterally but not contralaterally at 30 min PO (Fig. 3) , while IL-6 was elevated bilaterally (Fig. 2) . IL-6 co-localized with neuronal marker NeuN and microglia marker Iba1. Microglia are pivotal CNS immune effectors which respond to neuronal damage by releasing pro-inflammatory cytokines (Dheen et al. 2005; Balasubramaniam et al. 2009 ), which augment neurotoxicity of injured neurons (Polazzi and Contestabile 2002; Podbielska et al. 2016 ). Our observations suggest that spinal cord microglia may be activated very early after L5-VRT and contribute to up-regulation of IL-6.
To further identify early changes in spinal glial cells following motor fiber injury, levels of ED1/Iba1 (macrophage/microglia), GFAP (astrocyte), and CNPase (oligodendrocyte) markers were analyzed. The data showed that bilateral levels of ED1/Iba1, but not GFAP or CNPase, were increased in SDH and SVH at 30 min following L5-VRT compared to naive and sham-operated rats (Fig. 7a-d) . Consistent with previous observations (Vilhardt 2005) , resting SDH microglia in naive animals [ Fig. 7e(a) ] exhibited small somas with fine processes. When activated by VRT surgery, microglia took on ameboid shapes [ Fig. 7e(b) ].
To determine whether spinal microglia are responsible for VRT-induced IL-6 up-regulation, we depleted spinal microglia by intrathecal injection of Mac-1-saporin and monitored the effect of VRT surgery on spinal IL-6 expression at 30 min PO (Fig. 8a) . Compared to VRT-operated control rats that received NaCl, Mac-1-saporin strikingly inhibited Iba1-positive microglias and IL-6-positive neurons in bilateral spinal cord (Fig. 8b-d ). These observations suggest that activated spinal microglia contribute to IL-6 over-expression following motor fiber injury.
We also evaluated the role of spinal microglia on induction of mechanical allodynia following L5-VRT. The data showed that targeting spinal microglia with Mac-1-saporin delayed the onset of VRT-induced mechanical allodynia both ipsilaterally and contralaterally (Fig. 9) .
Discussion
Many theories have been proposed to explain the mechanisms underlying neuropathic pain, yet the mechanisms by which disease progression is triggered remain undefined. post-operative (PO) 30 min. The NaCl and non-targeting scramble control shRNA (PAVT1) had no effect. Blots are shown above, quantitative data are shown below. b-actin was used as a loading control. N = 3 rats/group, *p < 0.05, **p < 0.01, ***p < 0.001 (Student's t-test) versus sham group,
Since neuronal degeneration and dysfunction are thought to occur at the onset of axonal transection, it is possible damaged neurons release factors that not only bring about their own destruction (Ma 2013; Ma et al. 2013; Yang et al. 2013; Zang et al. 2015) but also promote microglial activation (Kim et al. 2005; Podbielska et al. 2016 ) that contributes to the induction of neuropathic pain.
Motor fiber injury up-regulates IL-6 in spinal cord at a very early stage Recent evidence indicates a contribution of spinal IL-6 in pain hypersensitivity (Vazquez et al. 2012; Wei et al. 2013 ). In the L5-VRT rat model, motor fiber injury significantly impairs the function of GABAergic synapses among spinal dorsal horn neurons (Huang et al. 2016) and this may affect IL-6 through suppression of GABA-induced inhibitory synaptic currents (Kawasaki et al. 2008) . Conversely, decreased GLT-1 levels induced by injection of IL-6 receptor neutralizing antibodies may explain the analgesic effect of this antibody in neuropathic pain (Guptarak et al. 2013) . Clinical observations also indicate that high serum IL-6 levels are closely associated with less favorable recovery in patients with lumbar radicular pain (Schistad et al. 2014 ).
However, no evidence had previously shown very early changes in spinal IL-6 expression after nerve injury. Our earlier work showed that motor nerve injury increased expression of IL-6 in bilateral spinal dorsal horn and ventral horn by day 1 following VRT surgery (Wei et al. 2013) . In this study, spinal IL-6 expression was induced within 24 h PO and abnormal IL-6 levels in spinal cord were detected at 20 min after L5-VRT. Exogenous administration of proinflammatory cytokines including Tumor Necrosis Factor (TNF), IL-1, and IL-6 elicits allodynia and hyperalgesia (Sommer and Kress 2004; Wei et al. 2007 Wei et al. , 2012 . Furthermore, these three cytokines induce the production of each other and act synergistically (Watkins et al. 1999) . This leads to the possibility of positive feedback loops that could induce chronic pain if not appropriately regulated. Inhibition of IL-6 expression as early as possible after nerve injury could therefore be effective in suppressing central sensitization and alleviating chronic pain.
CALP2 contributes to IL-6 expression in spinal neurons
Calpain has been proposed as one of the earliest mediators of pro-inflammatory cytokine up-regulation in injured peripheral nerve (Uceyler et al. 2007) . The activity of calpain can be regulated through association with its intrinsic inhibitor calpastatin (Guroff 1964; Murachi et al. 1989) . In inflammatory diseases such as rheumatoid arthritis, over-expressing calpastatin or administration of calpain inhibitor suppresses IL-6 production in vitro and in vivo, while over-expressing calpain enhances the level of IL-6 (Yoshifuji et al. 2005; Iguchi-Hashimoto et al. 2011) . Our recent work reveals the contribution of CALP2 to IL-6 up-regulation in DRG neurons in L5-VRT rats (Zang et al. 2015) . Here, we mainly focused on the spinal cord to further establish causality between CALP2 and IL-6 expression following L5-VRT.
Double immunofluorescence staining showed that the majority of CALP2 positive neurons expressed IL-6 (Fig. 4a) , and the initiation of increased CALP2 in ipsilateral SDH at 10 min PO preceded increased IL-6 at 20 min PO ( Fig. 4b  and c) . Furthermore, knockdown of CALP2 prevented VRTinduced spinal IL-6 overproduction ( Fig. 5) as well as the mechanical allodynia on bilateral sides ( Fig. 6e and f) . All of these observations support a very early CALP2 role in the up-regulation of IL-6 in spinal cord neurons following motor nerve injury. The molecular mechanism by which CALP2 regulates the expression of IL-6 may involve the activation of Iba1 was detected as early as PO 20 min, peaked at PO 3 days bilaterally, and remained at a significant level at PO 7 day ipsilaterally but not contralaterally (J). N = 5 rats/group, *p < 0.05, **p < 0.01, ***p < 0.001 (Student's t-test) versus naive rat.
NF-jB, an important signaling pathway initiating the transcription of pro-inflammatory cytokines (Pahl 1999) , via cleavage of inhibitor IjBa in the cytoplasm (Chen et al. 1997; Iguchi-Hashimoto et al. 2011) . How does the L5-VRT induce protein changes in spinal ventral horn and dorsal horn? L5-VRT surgery does not injure the neighboring dorsal root (Li et al. 2002) and DRG neurons are not damaged (Wei et al. 2013) . Since increased CALP2 in both distal-and proximal-stump of L5 ventral root starts at 10 min and peaks at 30 min after VRT surgery (Zang et al. 2015) , the up-regulation of CALP2 in spinal ventral horn may result from neurodegeneration of damaged neurons themselves, while protein changes in spinal dorsal horn may arise from activated glial cells Wei et al. 2013) or the input of uninjured primary afferents (Zang et al. 2015) . Since calpain is a calcium-dependent cysteine protease, high levels of extracellular calcium produced by damaged ventral root might also trigger CALP2 over-expression in uninjured neighboring dorsal root.
The potential role of spinal microglia in IL-6 expression and mirror-image pain Spinal microglia activation is associated with the development of neuropathic pain (Suter et al. 2007; Ji et al. 2013; Jeong et al. 2016) . Pathologically, calpain has been found to activate microglia and to be involved in activation of T cells in demyelinating conditions (Guyton et al. 2010; Smith et al. 2011; Trager et al. 2014) . Injured neurons can release signaling molecules including cytokines and calpain to recruit microglia and enhance their activities (Biber et al. 2007; Podbielska et al. 2016) . Activated microglia also produce calpain (Podbielska et al. 2016 ) and pro-inflammatory cytokines (McMahon et al. 2005) , including IL-6 (Han et al. 2013; Spittau et al. 2013; Fonken et al. 2015) . In our VRT model, spinal IL-6 up-regulation was observed in both astrocytes and microglia at day 7 after surgery (Wei et al. 2013) . In this study, within 30 min of L5-VRT only ED1/ Iba1 (macrophage/microglia marker) but not GFAP (astrocyte marker) or CNPase (oligodendrocyte marker) was elevated (Fig. 7) , and only IL-6 and Iba1co-localization was observed (Fig. 2f and g ). Furthermore, spinal CALP2 co-localized with NeuN (neuronal marker) but not GFAP or Iba1 (Fig. 3g and h ), suggesting that activated microglia might be another source of IL-6 expression at very early stages following VRT surgery. This may explain the partial inhibitory effect of CALP2 knockdown on increased IL-6 in ipsilateral spinal dorsal horn (Fig. 5) .
Clinically, patients with unilateral trauma or inflammation in an arm or leg also sense mirror-image pain in the contralateral limb (Koltzenburg et al. 1999; Huang and Yu 2010; Konopka et al. 2012) . Apparent mirror-image pain can also be detected (Figs 6 and 9) in L5-VRT rats (Li et al. 2002; Xu et al. 2006) . However, mechanisms underlying the expansion of pain to contralateral sites are not well defined. Interestingly, microglia have recently been implicated in mirror-image pain in an inflammatory pain model (Schreiber et al. 2008) . One possible mechanism involves spinal gap junction activation. Treatment with a gap junction decoupler reversed neuropathy-induced mirrorimage pain via suppression of pro-inflammatory cytokine release by distantly activated glia (Spataro et al. 2004 ). To Fig. 9 Intrathecal pre-treatment with Mac-1-saporin delayed the onset of ventral root transection (VRT)-induced mechanical allodynia. (a-f) A significant decrease in paw withdrawal threshold was detected ipsilaterally at day 1 post-operative (PO) in NaCl-treated group (a), day 3 in saporin group (c) and day 7 in the Mac-1-saporin group (e). The inhibitory effect of intrathecal Mac-1-saporin was also evident in contralateral side (b, d and f) . N = 6-7 rats/group, *p < 0.05, **p < 0.01 (KruskalWallis H test) versus PO day 1.
further clarify the role of microglia in mirror-image pain induced by motor nerve injury, the time-course of changes in Iba1 was analyzed, and selective depletion of microglia by intrathecal Mac-1-saporin was used to observe the effects of microglia on spinal IL-6 expression and painrelated behavior. We found that Iba1 was increased as early as 20 min and peaked at 3 days after L5-VRT (Fig. 7e and  f) , and the cellular morphology of microglia changed from a small soma with fine processes in the resting state to an ameboid shape when activated (Fig. 7, a and b) , possibly related to their function as phagocytes (Vilhardt 2005) . The regulation of microglia is multifactorial, including 'on' and 'off' activation signals from neurons (Biber et al. 2007) . The activation of microglia as a consequence of neuronal damage intensifies their neurotoxicity (Polazzi and Contestabile 2002) , and the microglial response to neuronal injury can be long-lived and self-enhancing (Lull and Block 2010) as shown by increased Iba1 at 7 days PO ( Fig. 7e  and f) . Furthermore, depletion of microglia by Mac-1-saporin successfully inhibited IL-6 up-regulation (Fig. 8 ) and attenuated bilateral VRT-induced mechanical allodynia (Fig. 9 ). These observations strongly suggest that activated microglia induced by motor fiber injury might be responsible for early abnormal bilateral spinal cord IL-6 expression initiating mirror-image pain.
Based on our findings, we propose a cascade of events triggering neuropathic pain following motor nerve injury: damaged ventral horn motor neurons rapidly produce CALP2 following injury, which directly triggers IL-6 expression that activates neighboring microglia (Podbielska et al. 2016) ; the latter release IL-6 into ipsilateral spinal dorsal horn (~VRT 20 min) and then contralateral spinal cord (VRT 30 min), inducing mirror-image pain. Thus, blockade of CALP2 and/ or microglia activation might prove effective as therapy for neuropathic pain.
